<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10(4)</volume><submitter>Sebbagh P</submitter><pubmed_abstract>Platelet-rich plasma (PRP) preparations have recently become widely available in sports medicine, facilitating their use in regenerative therapy for ligament and tendon affections. Quality-oriented regulatory constraints for PRP manufacturing and available clinical experiences have underlined the critical importance of process-based standardization, a pre-requisite for sound and homogeneous clinical efficacy evaluation. This retrospective study (2013-2020) considered the standardized GMP manufacturing and sports medicine-related clinical use of autologous PRP for tendinopathies at the Lausanne University Hospital (Lausanne, Switzerland). This study included 48 patients (18-86 years of age, with a mean age of 43.4 years, and various physical activity levels), and the related PRP manufacturi</pubmed_abstract><journal>Bioengineering (Basel, Switzerland)</journal><pagination>409</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10135571</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Process Optimization and Efficacy Assessment of Standardized PRP for Tendinopathies in Sports Medicine: Retrospective Study of Clinical Files and GMP Manufacturing Records in a Swiss University Hospital.</pubmed_title><pmcid>PMC10135571</pmcid><pubmed_authors>Scaletta C</pubmed_authors><pubmed_authors>Raffoul W</pubmed_authors><pubmed_authors>Gremeaux V</pubmed_authors><pubmed_authors>Hirt-Burri N</pubmed_authors><pubmed_authors>Applegate LA</pubmed_authors><pubmed_authors>Sebbagh P</pubmed_authors><pubmed_authors>Abdel-Sayed P</pubmed_authors><pubmed_authors>Laurent A</pubmed_authors><pubmed_authors>Gremion G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Process Optimization and Efficacy Assessment of Standardized PRP for Tendinopathies in Sports Medicine: Retrospective Study of Clinical Files and GMP Manufacturing Records in a Swiss University Hospital.</name><description>Platelet-rich plasma (PRP) preparations have recently become widely available in sports medicine, facilitating their use in regenerative therapy for ligament and tendon affections. Quality-oriented regulatory constraints for PRP manufacturing and available clinical experiences have underlined the critical importance of process-based standardization, a pre-requisite for sound and homogeneous clinical efficacy evaluation. This retrospective study (2013-2020) considered the standardized GMP manufacturing and sports medicine-related clinical use of autologous PRP for tendinopathies at the Lausanne University Hospital (Lausanne, Switzerland). This study included 48 patients (18-86 years of age, with a mean age of 43.4 years, and various physical activity levels), and the related PRP manufacturi</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Mar</publication><modification>2025-04-04T11:05:10.89Z</modification><creation>2025-04-04T11:05:10.89Z</creation></dates><accession>S-EPMC10135571</accession><cross_references><pubmed>37106596</pubmed><doi>10.3390/bioengineering10040409</doi></cross_references></HashMap>